News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
583,147 Results
Type
Article (63212)
Company Profile (127)
Press Release (519808)
Section
Business (159241)
Career Advice (2495)
Deals (28686)
Drug Delivery (120)
Drug Development (72646)
Employer Resources (155)
FDA (15943)
Job Trends (12655)
News (283785)
Policy (30388)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2823)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (80)
Alliances (39519)
ALS (86)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (124)
Approvals (15908)
Artificial intelligence (228)
Autoimmune disease (19)
Automation (11)
Bankruptcy (316)
Best Places to Work (9787)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (82)
Bladder cancer (60)
Brain cancer (25)
Breast cancer (243)
Cancer (1930)
Cardiovascular disease (168)
Career advice (2090)
Career pathing (32)
CAR-T (140)
Cell therapy (391)
Cervical cancer (19)
Clinical research (58433)
Collaboration (690)
Compensation (446)
Complete response letters (29)
COVID-19 (2669)
CRISPR (40)
C-suite (207)
Cystic fibrosis (95)
Data (1816)
Decentralized trials (2)
Denatured (16)
Depression (47)
Diabetes (252)
Diagnostics (5562)
Digital health (14)
Diversity (6)
Diversity, equity & inclusion (42)
Drug discovery (94)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (88)
Earnings (59367)
Editorial (39)
Employer branding (21)
Employer resources (139)
Events (81040)
Executive appointments (612)
FDA (17038)
Featured Employer (35)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (627)
Gene editing (99)
Generative AI (21)
Gene therapy (292)
GLP-1 (766)
Government (4023)
Grass and pollen (4)
Guidances (45)
Healthcare (16167)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (122)
Indications (23)
Infectious disease (2805)
Inflammatory bowel disease (129)
Inflation Reduction Act (9)
Influenza (47)
Intellectual property (80)
Interviews (460)
IPO (14210)
IRA (48)
Job creations (3259)
Job search strategy (1747)
Kidney cancer (10)
Labor market (28)
Layoffs (495)
Leadership (19)
Legal (7124)
Liver cancer (72)
Lung cancer (281)
Lymphoma (126)
Machine learning (2)
Management (52)
Manufacturing (261)
MASH (65)
Medical device (11824)
Medtech (11827)
Mergers & acquisitions (14907)
Metabolic disorders (683)
Multiple sclerosis (68)
NASH (22)
Neurodegenerative disease (87)
Neuropsychiatric disorders (31)
Neuroscience (1906)
NextGen: Class of 2025 (5444)
Non-profit (3772)
Northern California (2261)
Now hiring (18)
Obesity (380)
Opinion (215)
Ovarian cancer (67)
Pain (79)
Pancreatic cancer (73)
Parkinson's disease (132)
Partnered (16)
Patents (204)
Patient recruitment (88)
Peanut (48)
People (51230)
Pharmaceutical (34)
Pharmacy benefit managers (21)
Phase I (17610)
Phase II (25390)
Phase III (20269)
Pipeline (982)
Podcasts (78)
Policy (130)
Postmarket research (2553)
Preclinical (7587)
Press Release (45)
Prostate cancer (92)
Psychedelics (35)
Radiopharmaceuticals (222)
Rare diseases (374)
Real estate (4702)
Recruiting (62)
Regulatory (21265)
Reports (32)
Research institute (2326)
Resumes & cover letters (409)
Rett syndrome (3)
RNA editing (2)
RSV (42)
Schizophrenia (70)
Series A (118)
Series B (76)
Service/supplier (9)
Sickle cell disease (54)
Southern California (1907)
Special edition (16)
Spinal muscular atrophy (141)
Sponsored (32)
Startups (3014)
State (1)
Stomach cancer (16)
Supply chain (63)
The Weekly (60)
United States (19180)
Vaccines (737)
Venture capitalists (38)
Webinars (12)
Weight loss (281)
Women's health (32)
Worklife (18)
Date
Today (109)
Last 7 days (570)
Last 30 days (2416)
Last 365 days (31234)
2025 (7406)
2024 (32467)
2023 (36417)
2022 (46901)
2021 (50586)
2020 (47995)
2019 (39372)
2018 (29709)
2017 (29839)
2016 (28403)
2015 (31176)
2014 (24713)
2013 (21588)
2012 (22877)
2011 (22954)
2010 (21201)
Location
Africa (775)
Alabama (43)
Alaska (7)
Arizona (174)
Arkansas (12)
Asia (34637)
Australia (6480)
California (5043)
Canada (1494)
China (399)
Colorado (226)
Connecticut (252)
Delaware (119)
Europe (84350)
Florida (765)
Georgia (173)
Hawaii (1)
Idaho (43)
Illinois (438)
India (22)
Indiana (238)
Iowa (9)
Japan (134)
Kansas (85)
Kentucky (16)
Louisiana (5)
Maine (61)
Maryland (795)
Massachusetts (3816)
Michigan (174)
Minnesota (316)
Mississippi (1)
Missouri (67)
Montana (14)
Nebraska (19)
Nevada (50)
New Hampshire (54)
New Jersey (1456)
New Mexico (19)
New York (1431)
North Carolina (880)
North Dakota (8)
Northern California (2261)
Ohio (163)
Oklahoma (9)
Oregon (28)
Pennsylvania (1110)
Puerto Rico (10)
Rhode Island (18)
South America (1136)
South Carolina (16)
South Dakota (1)
Southern California (1907)
Tennessee (81)
Texas (719)
Utah (136)
Virginia (118)
Washington D.C. (57)
Washington State (469)
West Virginia (3)
Wisconsin (48)
583,147 Results for "queen s university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
Business
Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)
Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics.
April 10, 2023
·
5 min read
Press Releases
Red Queen Therapeutics Announces Expanded Licensing Agreement, Progress in Its Pan-Influenza Program
December 3, 2024
·
4 min read
TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)
TC BioPharm PLC is proud to announce it has entered into a collaboration agreement with Queen Mary University of London to research the therapeutic potential of gamma-delta T cells for the treatment of mucosal infections.
September 5, 2023
·
4 min read
Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System
Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System.
September 27, 2022
·
7 min read
Press Releases
Rosalind Franklin University’s Helix 51 Incubator Welcomes Monopar Therapeutics
Monopar’s pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease
January 23, 2025
·
1 min read
Press Releases
Apple Tree Partners Launches Red Queen Therapeutics to Bring Potentially Lifesaving Treatments to People at Greatest Risk from Viral Infections
August 6, 2024
·
7 min read
Business
Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic Collaboration Agreement
Envisagenics , an Artificial Intelligence (“AI”)-driven biotechnology company that delivers therapies for RNA splicing diseases, today announced a research collaboration agreement with Cancer Research Horizons, Cancer Research UK’s innovation engine, and Queen Mary University of London.
December 13, 2022
·
5 min read
icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)
icometrix is proud to announce that, together with Queen Mary University of London, it has been awarded the prestigious AI Award in Health and Care.
March 3, 2023
·
11 min read
Press Releases
LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
February 25, 2025
·
4 min read
1 of 58,315
Next
